SRC Gene: Complete Identifier and Functional Mapping Reference
╔═══════════════════════════════════════════════════════════════════════════════╗
║ ║
║ ███████╗██████╗ ██████╗ ║
║ ██╔════╝██╔══██╗██╔════╝ ║
║ ███████╗██████╔╝██║ ║
║ ╚════██║██╔══██╗██║ ║
║ ███████║██║ ██║╚██████╗ ║
║ ╚══════╝╚═╝ ╚═╝ ╚═════╝ ║
║ ║
║ Proto-oncogene tyrosine-protein kinase Src ║
║ Cross-Database Identifier & Functional Mapping Reference ║
║ ║
╚═══════════════════════════════════════════════════════════════════════════════╝
Section 1: Gene Identifiers
Primary Gene Identifiers
| Database | Identifier | Description |
|---|
| HGNC | HGNC:11283 | Approved symbol: SRC |
| HGNC Name | SRC proto-oncogene, non-receptor tyrosine kinase | Official full name |
| Ensembl Gene | ENSG00000197122 | Human gene (GRCh38) |
| NCBI Entrez | 6714 | Gene ID |
| OMIM | 190090 | Gene/locus entry |
Genomic Location (GRCh38/hg38)
| Attribute | Value |
|---|
| Chromosome | 20 |
| Start Position | 37,344,673 |
| End Position | 37,406,050 |
| Strand | + (positive) |
| Cytoband | 20q11.23 |
| Gene Length | 61,378 bp |
| Biotype | protein_coding |
Additional Gene Attributes
| Attribute | Value |
|---|
| Locus Type | gene with protein product |
| Gene Groups | SH2 domain containing; Src family tyrosine kinases |
| Previous Symbols | SRC1 |
| Aliases | ASV, c-src |
| Status | Approved |
Section 2: Transcript Identifiers
Ensembl Transcripts
Total Transcript Count: 29
| Transcript ID | Biotype | Start | End | Notes |
|---|
| ENST00000373578 | protein_coding | 37,346,140 | 37,406,050 | Major transcript |
| ENST00000358208 | protein_coding | 37,384,150 | 37,406,050 | |
| ENST00000373558 | protein_coding | 37,384,150 | 37,406,050 | |
| ENST00000373567 | protein_coding | 37,383,668 | 37,406,050 | |
| ENST00000692112 | protein_coding | 37,346,109 | 37,406,050 | |
| ENST00000692423 | protein_coding | 37,346,140 | 37,406,050 | |
| ENST00000693012 | protein_coding | 37,346,140 | 37,387,801 | |
| ENST00000876226 | protein_coding | 37,344,673 | 37,405,431 | |
| ENST00000876227 | protein_coding | 37,344,681 | 37,405,429 | |
| ENST00000876228 | protein_coding | 37,344,714 | 37,405,418 | |
| ENST00000876229 | protein_coding | 37,344,718 | 37,405,415 | |
| ENST00000876230 | protein_coding | 37,345,108 | 37,405,414 | |
| ENST00000876231 | protein_coding | 37,345,138 | 37,405,432 | |
| ENST00000876232 | protein_coding | 37,345,213 | 37,405,418 | |
| ENST00000876233 | protein_coding | 37,345,936 | 37,405,418 | |
| ENST00000876234 | protein_coding | 37,346,125 | 37,405,415 | |
| ENST00000876235 | protein_coding | 37,346,140 | 37,405,415 | |
| ENST00000876236 | protein_coding | 37,346,140 | 37,404,632 | |
| ENST00000876237 | protein_coding | 37,383,899 | 37,405,420 | |
| ENST00000921683 | protein_coding | 37,345,711 | 37,405,415 | |
| ENST00000921684 | protein_coding | 37,346,324 | 37,405,415 | |
| ENST00000950593 | protein_coding | 37,383,596 | 37,405,416 | |
| ENST00000467556 | retained_intron | 37,400,149 | 37,401,957 | |
| ENST00000472968 | retained_intron | 37,384,323 | 37,394,174 | |
| ENST00000489153 | retained_intron | 37,393,745 | 37,397,746 | |
| ENST00000493775 | retained_intron | 37,402,313 | 37,403,031 | |
| ENST00000477066 | CDS_not_defined | 37,396,426 | 37,405,422 | |
| ENST00000477475 | CDS_not_defined | 37,400,251 | 37,402,292 | |
| ENST00000497734 | CDS_not_defined | 37,344,685 | 37,382,787 | |
RefSeq Transcripts (Human, Chromosome 20)
| Accession | Type | Status | MANE Select |
|---|
| NM_198291 | mRNA | REVIEWED | ✓ MANE Select |
| NM_005417 | mRNA | REVIEWED | |
RefSeq Proteins (Human)
| Accession | Status | MANE Select |
|---|
| NP_938033 | REVIEWED | ✓ MANE Select |
| NP_005408 | REVIEWED | |
CCDS Identifiers
Exon Information (Canonical Transcript ENST00000373578)
Total Exon Count: 14
| Exon ID | Start | End | Strand |
|---|
| ENSE00001460945 | 37,346,140 | 37,346,255 | + |
| ENSE00001460974 | 37,365,204 | 37,365,277 | + |
| ENSE00001798147 | 37,382,619 | 37,382,786 | + |
| ENSE00000661877 | 37,384,150 | 37,384,403 | + |
| ENSE00003544319 | 37,386,075 | 37,386,174 | + |
| ENSE00000661879 | 37,393,895 | 37,393,993 | + |
| ENSE00003523341 | 37,394,174 | 37,394,277 | + |
| ENSE00003678936 | 37,396,162 | 37,396,311 | + |
| ENSE00003516229 | 37,397,699 | 37,397,854 | + |
| ENSE00003564760 | 37,400,115 | 37,400,294 | + |
| ENSE00003669255 | 37,401,602 | 37,401,678 | + |
| ENSE00003543788 | 37,402,435 | 37,402,588 | + |
| ENSE00003638193 | 37,402,749 | 37,402,880 | + |
| ENSE00001460955 | 37,403,171 | 37,406,050 | + |
Section 3: Protein Identifiers
UniProt Accessions
| Accession | Status | Name | Mass | Length |
|---|
| P12931 | ✓ Reviewed (Swiss-Prot) | Proto-oncogene tyrosine-protein kinase Src | 59,835 Da | 536 aa |
| A0A8I5KYU4 | Unreviewed (TrEMBL) | - | - | - |
Alternative Names:
- Proto-oncogene c-Src
- pp60c-src
RefSeq Proteins
| Accession | Type | Status | MANE |
|---|
| NP_938033 | protein | REVIEWED | ✓ |
| NP_005408 | protein | REVIEWED | |
Protein Domains and Families
Total Domain Annotations: 11
| InterPro ID | Name | Type |
|---|
| IPR050198 | Non-receptor_tyrosine_kinases | Family |
| IPR000719 | Prot_kinase_dom | Domain |
| IPR000980 | SH2 | Domain |
| IPR001245 | Ser-Thr/Tyr_kinase_cat_dom | Domain |
| IPR001452 | SH3_domain | Domain |
| IPR020635 | Tyr_kinase_cat_dom | Domain |
| IPR008266 | Tyr_kinase_AS | Active_site |
| IPR017441 | Protein_kinase_ATP_BS | Binding_site |
| IPR011009 | Kinase-like_dom_sf | Homologous_superfamily |
| IPR036028 | SH3-like_dom_sf | Homologous_superfamily |
| IPR036860 | SH2_dom_sf | Homologous_superfamily |
Section 4: Structure Identifiers
Experimental Structures (PDB)
Total PDB Structure Count: 79
| PDB ID | Method | Resolution (Å) | Title |
|---|
| 1FMK | X-ray | 1.50 | Crystal structure of human tyrosine-protein kinase C-SRC |
| 2SRC | X-ray | 1.50 | Human tyrosine-protein kinase C-SRC with AMP-PNP |
| 7NG7 | X-ray | 1.50 | Src kinase bound to eCF506 trapped in inactive conformation |
| 9OFX | X-ray | 1.45 | c-Src SH3 domain in H32 space group |
| 1O43 | X-ray | 1.50 | SH2 in complex with RU82129 |
| 1O4A | X-ray | 1.50 | SH2 in complex with RU82197 |
| 1O4R | X-ray | 1.50 | SH2 in complex with RU78783 |
| 6C4S | X-ray | 1.50 | cSrc SH3 Domain in complex with Choline Kinase |
| 8VCF | X-ray | 1.50 | Superbinder Src SH2 domain |
| 1O42 | X-ray | 1.70 | SH2 in complex with RU81843 |
| 4F5B | X-ray | 1.57 | Triple mutant Src SH2 domain with phosphotyrosine |
| 8VCG | X-ray | 1.61 | Mutant Src SH2 domain with phosphotyrosine |
| 1A09 | X-ray | 2.00 | C-src (SH2 domain) complexed |
| 1Y57 | X-ray | 1.91 | Unphosphorylated c-Src in complex with inhibitor |
| 1YOJ | X-ray | 1.95 | Src kinase domain |
| 2BDF | X-ray | 2.10 | Src kinase with inhibitor AP23451 |
| 4MXO | X-ray | 2.11 | Src kinase bound to bosutinib |
| 6E6E | X-ray | 2.15 | DGY-06-116 covalent inhibitor of SRC kinase |
| 9NS0 | NMR | - | Ground state of Src kinase domain |
| 9NS1 | NMR | - | Intermediate state of Src kinase domain |
| 1HCS | NMR | - | Human SRC SH2 domain complex |
| 1HCT | NMR | - | Human SRC SH2 domain complex |
... and 57 additional structures
Predicted Structures (AlphaFold)
| Model ID | Global pLDDT | Sequence Length | Fraction Very High Confidence |
|---|
| P12931 | 84.59 | 4,214 | 0.68 (68%) |
Section 5: Cross-Species Orthologs
Model Organism Orthologs
| Organism | Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000027646 | Src | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000009495 | Src | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000008107 | src | protein_coding |
Human Paralogs (Src Family and Related Kinases)
Total Paralog Count: 32
| Gene ID | Symbol | Family |
|---|
| ENSG00000010810 | FYN | Src family |
| ENSG00000176105 | YES1 | Src family |
| ENSG00000182866 | LCK | Src family |
| ENSG00000254087 | LYN | Src family |
| ENSG00000101336 | HCK | Src family |
| ENSG00000136573 | BLK | Src family |
| ENSG00000000938 | FGR | Src family |
| ENSG00000111816 | FRK | Src-related |
| ENSG00000101213 | PTK6 | Src-related |
| ENSG00000125508 | SRMS | Src-related |
| ENSG00000097007 | ABL1 | Non-receptor TK |
| ENSG00000143322 | ABL2 | Non-receptor TK |
| ENSG00000096968 | JAK2 | JAK family |
| ENSG00000162434 | JAK1 | JAK family |
| ENSG00000105639 | JAK3 | JAK family |
| ENSG00000105397 | TYK2 | JAK family |
| ENSG00000169398 | PTK2 | Focal adhesion kinase |
| ENSG00000120899 | PTK2B | Focal adhesion kinase |
| ENSG00000165025 | SYK | Spleen TK |
| ENSG00000115085 | ZAP70 | Immune signaling |
Section 6: Clinical Variants & AI Predictions
ClinVar Variant Summary
Total Variant Count: 111+
| Classification | Count |
|---|
| Pathogenic | 1 |
| Likely Pathogenic | 1 |
| Uncertain Significance (VUS) | 35+ |
| Likely Benign | 20+ |
| Benign | 30+ |
| Benign/Likely Benign | 5 |
| Not Provided | 15+ |
Pathogenic/Likely Pathogenic Variants
| ClinVar ID | HGVS Notation | Classification | Condition |
|---|
| 12573 | NM_198291.3(SRC):c.1591C>T (p.Gln531Ter) | Pathogenic | Thrombocytopenia |
| 225689 | NM_198291.3(SRC):c.1579G>A (p.Glu527Lys) | Likely Pathogenic | Thrombocytopenia |
Sample VUS Variants (Top 20)
| ClinVar ID | HGVS Notation | Classification |
|---|
| 100851 | c.1200C>G (p.Asn400Lys) | Uncertain significance |
| 2234627 | c.1018G>A (p.Val340Ile) | Uncertain significance |
| 2310404 | c.811C>T (p.Arg271Trp) | Uncertain significance |
| 2388133 | c.475C>T (p.Arg159Trp) | Uncertain significance |
| 2475250 | c.296C>T (p.Thr99Met) | Uncertain significance |
| 2477836 | c.327G>T (p.Glu109Asp) | Uncertain significance |
| 2548214 | c.1439G>A (p.Arg480Gln) | Uncertain significance |
| 2572134 | c.1585C>G (p.Gln529Glu) | Uncertain significance |
| 2584809 | c.919C>T (p.Pro307Ser) | Uncertain significance |
| 2614414 | c.869A>G (p.Asn290Ser) | Uncertain significance |
| 2619551 | c.890T>C (p.Ile297Thr) | Uncertain significance |
| 3169832 | c.529G>T (p.Val177Leu) | Uncertain significance |
| 3169833 | c.871G>T (p.Gly291Cys) | Uncertain significance |
| 3252560 | c.1250_1253del (p.Asn417fs) | Uncertain significance |
| 3252895 | c.1039+5G>C | Uncertain significance |
| 3322569 | c.1460C>T (p.Pro487Leu) | Uncertain significance |
| 3322570 | c.1513G>C (p.Glu505Gln) | Uncertain significance |
| 3449216 | c.242C>A (p.Pro81Gln) | Uncertain significance |
| 3449217 | c.100G>C (p.Ala34Pro) | Uncertain significance |
| 3764601 | c.1070C>T (p.Thr357Ile) | Uncertain significance |
SpliceAI Predictions
Total Predicted Splice Variants: 3,484
Top 20 High-Impact Splice Predictions:
| Variant | Gene | Effect | Delta Score |
|---|
| 20:37346252:CCAG:C | SRC | donor_loss | 0.99 |
| 20:37346254:AG:A | SRC | donor_loss | 0.99 |
| 20:37346257:T:A | SRC | donor_loss | 0.99 |
| 20:37346256:G:GG | SRC | donor_gain | 0.95 |
| 20:37346258:GAGC:G | SRC | donor_loss | 0.75 |
| 20:37346254:AGGTG:A | SRC | donor_gain | 0.74 |
| 20:37346251:CCCAG:C | SRC | donor_gain | 0.73 |
| 20:37346252:CCAGG:C | SRC | donor_gain | 0.73 |
| 20:37346253:CAGG:C | SRC | donor_gain | 0.73 |
| 20:37346255:GGTGA:G | SRC | donor_gain | 0.73 |
| 20:37346256:GTGAG:G | SRC | donor_gain | 0.73 |
| 20:37346257:T:TT | SRC | donor_gain | 0.73 |
| 20:37346258:GAGCG:G | SRC | donor_gain | 0.73 |
| 20:37346234:G:GT | SRC | donor_gain | 0.71 |
| 20:37346259:AGCGC:A | SRC | donor_gain | 0.71 |
| 20:37346228:C:CA | SRC | donor_gain | 0.70 |
| 20:37346250:GCCCA:G | SRC | donor_gain | 0.70 |
| 20:37346232:G:A | SRC | donor_gain | 0.68 |
| 20:37346235:C:T | SRC | donor_gain | 0.68 |
| 20:37346260:G:C | SRC | donor_gain | 0.67 |
AlphaMissense Predictions
Total Missense Predictions: 3,468
Top 20 Likely Pathogenic Predictions:
| Variant | Protein Change | AM Score | Classification |
|---|
| 20:37384169:A:C | S6R | 0.864 | likely_pathogenic |
| 20:37384171:C:A | S6R | 0.864 | likely_pathogenic |
| 20:37384171:C:G | S6R | 0.864 | likely_pathogenic |
| 20:37384174:G:C | K7N | 0.860 | likely_pathogenic |
| 20:37384174:G:T | K7N | 0.860 | likely_pathogenic |
| 20:37384157:G:C | G2R | 0.813 | likely_pathogenic |
| 20:37384168:G:C | K5N | 0.775 | likely_pathogenic |
| 20:37384168:G:T | K5N | 0.775 | likely_pathogenic |
| 20:37384172:A:G | K7E | 0.763 | likely_pathogenic |
| 20:37384180:G:C | K9N | 0.744 | likely_pathogenic |
| 20:37384180:G:T | K9N | 0.744 | likely_pathogenic |
| 20:37384173:A:G | K7M | 0.719 | likely_pathogenic |
| 20:37384166:A:G | K5E | 0.728 | likely_pathogenic |
| 20:37384173:A:C | K7T | 0.654 | likely_pathogenic |
| 20:37384179:A:T | K9M | 0.649 | likely_pathogenic |
| 20:37384158:G:A | G2D | 0.640 | likely_pathogenic |
| 20:37384187:A:C | S12R | 0.572 | likely_pathogenic |
| 20:37384189:C:A | S12R | 0.572 | likely_pathogenic |
| 20:37384189:C:G | S12R | 0.572 | likely_pathogenic |
| 20:37384160:A:C | S3R | 0.707 | likely_pathogenic |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways
Total Pathway Count: 69
| Pathway ID | Pathway Name | Disease Pathway |
|---|
| R-HSA-177929 | Signaling by EGFR | No |
| R-HSA-1227986 | Signaling by ERBB2 | No |
| R-HSA-354192 | Integrin signaling | No |
| R-HSA-354194 | GRB2:SOS provides linkage to MAPK signaling for Integrins | No |
| R-HSA-372708 | p130Cas linkage to MAPK signaling for integrins | No |
| R-HSA-4420097 | VEGFA-VEGFR2 Pathway | No |
| R-HSA-5218921 | VEGFR2 mediated cell proliferation | No |
| R-HSA-2682334 | EPH-Ephrin signaling | No |
| R-HSA-3928662 | EPHB-mediated forward signaling | No |
| R-HSA-3928663 | EPHA-mediated growth cone collapse | No |
| R-HSA-8853659 | RET signaling | No |
| R-HSA-1433557 | Signaling by SCF-KIT | No |
| R-HSA-201556 | Signaling by ALK | No |
| R-HSA-1257604 | PIP3 activates AKT signaling | No |
| R-HSA-5673000 | RAF activation | No |
| R-HSA-5674135 | MAP2K and MAPK activation | No |
| R-HSA-171007 | p38MAPK events | No |
| R-HSA-69231 | Cyclin D associated events in G1 | No |
| R-HSA-389356 | Co-stimulation by CD28 | No |
| R-HSA-389513 | Co-inhibition by CTLA4 | No |
| R-HSA-2029481 | FCGR activation | No |
| R-HSA-5607764 | CLEC7A (Dectin-1) signaling | No |
| R-HSA-30168 | Platelet activation | No |
| R-HSA-9009391 | Extra-nuclear estrogen signaling | No |
| R-HSA-9620244 | Long-term potentiation | No |
| R-HSA-8934903 | Receptor Mediated Mitophagy | No |
| R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | Yes |
| R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | Yes |
| R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | Yes |
| R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | Yes |
| R-HSA-9649948 | Signaling downstream of RAS mutants | Yes |
| R-HSA-9656223 | Signaling by RAF1 mutants | Yes |
| R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes | Yes |
Gene Ontology Annotations
Total GO Annotations: 121
Molecular Function (Top 20)
| GO ID | Term |
|---|
| GO:0004672 | protein kinase activity |
| GO:0004713 | protein tyrosine kinase activity |
| GO:0004715 | non-membrane spanning protein tyrosine kinase activity |
| GO:0005524 | ATP binding |
| GO:0005102 | signaling receptor binding |
| GO:0005178 | integrin binding |
| GO:0019899 | enzyme binding |
| GO:0020037 | heme binding |
| GO:0016004 | phospholipase activator activity |
| GO:0030296 | protein tyrosine kinase activator activity |
| GO:0030546 | signaling receptor activator activity |
| GO:0035255 | ionotropic glutamate receptor binding |
| GO:0042169 | SH2 domain binding |
| GO:0043274 | phospholipase binding |
| GO:0044325 | transmembrane transporter binding |
| GO:0045296 | cadherin binding |
| GO:0046875 | ephrin receptor binding |
| GO:0051117 | ATPase binding |
| GO:0051219 | phosphoprotein binding |
| GO:0070700 | BMP receptor binding |
Biological Process (Top 20)
| GO ID | Term |
|---|
| GO:0007165 | signal transduction |
| GO:0007173 | epidermal growth factor receptor signaling pathway |
| GO:0007179 | transforming growth factor beta receptor signaling pathway |
| GO:0007229 | integrin-mediated signaling pathway |
| GO:0018108 | peptidyl-tyrosine phosphorylation |
| GO:0030154 | cell differentiation |
| GO:0030168 | platelet activation |
| GO:0035556 | intracellular signal transduction |
| GO:0043066 | negative regulation of apoptotic process |
| GO:0048010 | vascular endothelial growth factor receptor signaling pathway |
| GO:0048013 | ephrin receptor signaling pathway |
| GO:0050900 | leukocyte migration |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
| GO:0051897 | positive regulation of PI3K/AKT signal transduction |
| GO:0010634 | positive regulation of epithelial cell migration |
| GO:0034446 | substrate adhesion-dependent cell spreading |
| GO:0048041 | focal adhesion assembly |
| GO:0045747 | positive regulation of Notch signaling pathway |
| GO:0090263 | positive regulation of canonical Wnt signaling pathway |
| GO:2000811 | negative regulation of anoikis |
Cellular Component (Top 20)
| GO ID | Term |
|---|
| GO:0005634 | nucleus |
| GO:0005737 | cytoplasm |
| GO:0005739 | mitochondrion |
| GO:0005743 | mitochondrial inner membrane |
| GO:0005764 | lysosome |
| GO:0005770 | late endosome |
| GO:0005829 | cytosol |
| GO:0005884 | actin filament |
| GO:0005886 | plasma membrane |
| GO:0005901 | caveola |
| GO:0005911 | cell-cell junction |
| GO:0005925 | focal adhesion |
| GO:0002102 | podosome |
| GO:0030054 | cell junction |
| GO:0032587 | ruffle membrane |
| GO:0045121 | membrane raft |
| GO:0048471 | perinuclear region of cytoplasm |
| GO:0070062 | extracellular exosome |
Section 8: Protein Interactions & Molecular Networks
STRING Protein-Protein Interactions
Total Interaction Count: 9,720+
Top 50 High-Confidence Interactors (Score ≥970):
| UniProt ID | Score | Protein Name |
|---|
| P49023 | 998 | Paxillin |
| P56945 | 998 | BCAR1 (p130Cas) |
| Q14247 | 997 | Cortactin (CTTN) |
| P03372 | 996 | Estrogen receptor alpha (ESR1) |
| P40763 | 996 | STAT3 |
| Q9Y490 | 996 | Talin-1 (TLN1) |
| P18206 | 995 | Vinculin |
| P46108 | 995 | CRK |
| P49407 | 995 | β-Arrestin-1 |
| P07900 | 994 | HSP90AA1 |
| P14317 | 994 | FLII |
| Q03135 | 994 | Caveolin-1 |
| Q9Y4G6 | 994 | TLN2 |
| P08238 | 993 | HSP90AB1 |
| P22681 | 993 | CBL |
| Q9Y4K3 | 991 | TNK2 |
| P29353 | 990 | SHC1 |
| P32121 | 989 | β-Arrestin-2 |
| P00533 | 988 | EGFR |
| Q05397 | 988 | PTK2 (FAK) |
| Q14289 | 987 | PTK2B (PYK2) |
| P29354 | 986 | SHC2 |
| P35222 | 986 | β-Catenin |
| P13931 | 983 | Glycogen synthase kinase-3β |
| P25388 | 983 | RRAS2 |
| P04626 | 980 | ERBB2 |
| Q06124 | 980 | PTPN11 (SHP2) |
| P31749 | 977 | AKT1 |
| P43405 | 976 | SYK |
| P17302 | 975 | GJA1 |
| Q9UKG1 | 974 | ASAP1 |
| P42768 | 973 | WAS |
| P05106 | 972 | Integrin β3 |
| P09619 | 972 | PDGFRB |
| P78352 | 964 | DLG4 |
| Q8N556 | 963 | AFDN |
| P35568 | 961 | IRS1 |
| P08069 | 959 | IGF1R |
| P12830 | 955 | CDH1 (E-cadherin) |
| Q14185 | 955 | DOCK1 |
| Q13094 | 953 | LCP2 |
| Q07666 | 949 | KHDRBS1 |
| Q9ULH1 | 947 | ASAP2 |
| P10275 | 944 | Androgen receptor |
| Q09472 | 943 | EP300 |
| P35968 | 938 | KDR (VEGFR2) |
| Q14511 | 929 | NEDD9 |
| P16070 | 926 | CD44 |
| Q9NP31 | 925 | SH3PXD2B |
| P27482 | 923 | CALM3 |
IntAct Physical Interactions
Total Curated Interactions: 801+
Top 20 High-Confidence Interactions:
| Partner | Interaction Type | Confidence |
|---|
| PTK2 (FAK) | physical association | 0.92 |
| ESR1 | association | 0.85 |
| KDR (VEGFR2) | physical association | 0.77 |
| LYN | association | 0.67 |
| HSP90AA1 | physical association | 0.67 |
| MED28 | physical association | 0.66 |
| PIK3R3 | physical association | 0.62 |
| ARRB1 | physical association | 0.62 |
| ASAP1 | physical association | 0.61 |
| PECAM1 | direct interaction | 0.59 |
| ABL1 | physical association | 0.59 |
| ARRB2 | physical association | 0.56 |
| CTNNB1 | phosphorylation | 0.54 |
| HK1 | physical association | 0.52 |
| STAT3 | enzymatic reaction | 0.44 |
| BCAR1 | enzymatic reaction | 0.44 |
| CDKN1B | phosphorylation reaction | 0.44 |
| TXNIP | direct interaction | 0.44 |
| CTTN | phosphorylation reaction | 0.44 |
| SHC1 | phosphorylation reaction | 0.44 |
Structural Similarity (ESM2)
Total Similar Proteins: 70
Top 20 Structurally Similar Proteins:
| UniProt ID | Top Similarity | Avg Similarity | Protein |
|---|
| P06241 | 1.0000 | 0.9955 | Fyn proto-oncogene |
| Q62844 | 1.0000 | 0.9956 | Src (mouse) |
| A1Y2K1 | 1.0000 | 0.9956 | Src homolog |
| P39688 | 1.0000 | 0.9955 | Src family kinase |
| P05480 | 0.9999 | 0.9949 | Src (chicken) |
| P06240 | 0.9999 | 0.9933 | LCK |
| Q01621 | 0.9999 | 0.9933 | Src-family kinase |
| Q04736 | 0.9998 | 0.9943 | YES1 |
| P63185 | 0.9998 | 0.9948 | Src homolog |
| P50545 | 0.9998 | 0.9928 | Tyrosine kinase |
| P06239 | 0.9997 | 0.9928 | LCK (human) |
| Q5PXS1 | 0.9997 | 0.9936 | Src-family kinase |
| Q95KR7 | 0.9997 | 0.9936 | Src homolog |
| P07947 | 0.9996 | 0.9943 | YES proto-oncogene |
| P07948 | 0.9996 | 0.9906 | LYN |
| P13115 | 0.9996 | 0.9952 | Src-family kinase |
| P13116 | 0.9996 | 0.9940 | Src-family kinase |
| F1RDG9 | 0.9995 | 0.9952 | Src homolog |
| P00523 | 0.9994 | 0.9957 | v-Src (viral) |
| P14234 | 0.9994 | 0.9943 | Src-family kinase |
Sequence Homology (DIAMOND)
Total Homologous Proteins: 273+
Top 20 by Identity:
| UniProt ID | Identity (%) | Bitscore | Protein |
|---|
| P00523 | 100.0 | 1068 | v-Src viral oncogene |
| P15054 | 100.0 | 1067 | PP60-SRC |
| P04049 | 100.0 | 1303 | RAF proto-oncogene |
| P10533 | 100.0 | 720 | Src family |
| A0JNB0 | 99.6 | 1114 | SRC homolog |
| P06241 | 99.6 | 1114 | FYN |
| P05480 | 99.4 | 1077 | c-Src (Gallus) |
| A1Y2K1 | 99.4 | 1115 | SRC homolog |
| O15197 | 99.3 | 2024 | Ephrin B3 |
| P00519 | 99.3 | 1866 | ABL1 |
| P06240 | 99.2 | 1056 | LCK |
| P14084 | 99.6 | 1065 | Src homolog |
| P14085 | 99.8 | 1057 | Src homolog |
| P00524 | 99.0 | 1060 | v-Src |
| P00525 | 99.0 | 1060 | v-Src |
| P00526 | 99.0 | 1061 | v-Src |
| P00527 | 98.9 | 1048 | pp60v-src |
| P09324 | 98.9 | 1046 | Src-related |
| P00520 | 98.9 | 1871 | ABL proto-oncogene |
| O08644 | 98.4 | 2010 | Ephrin type-B |
Section 9: Transcription Factor Regulatory Data
Upstream Regulators (TFs that regulate SRC)
Total Regulatory TFs: 32
| TF Gene | Regulation | Confidence |
|---|
| JUN | Activation | High |
| HNF1A | Activation | High |
| SP1 | Unknown | High |
| GTF2I | - | High |
| JDP2 | - | High |
| SP3 | - | High |
| AR | - | High |
| ESR1 | Unknown | High |
| AP1 | Activation | Low |
| EGR1 | - | Low |
| FOXO3 | - | Low |
| HIF1A | - | Low |
| HNF4A | - | Low |
| NCOA1 | - | Low |
| NCOA2 | - | Low |
| NCOA3 | Activation | Low |
| NFATC1 | Activation | Low |
| NFKB | - | Low |
| RBPJ | Activation | Low |
| RELA | - | Low |
| RELB | - | Low |
| STAT5A | - | Low |
| THRA | - | Low |
| ARNT | - | Low |
| ESR2 | - | Low |
| HHEX | - | Low |
| IER2 | - | Low |
| JUNB | - | Low |
| KAT7 | - | Low |
| MAFB | - | Low |
| NFIC | - | Low |
| TAF1 | Unknown | - |
SRC as Kinase: Downstream Signaling Targets
Total SIGNOR Entries: 560+
Top 50 Phosphorylation Substrates:
| Target | Effect | Mechanism | Score |
|---|
| BCAR1 | up-regulates activity | phosphorylation | 0.80 |
| CTNNB1 | up-regulates activity | phosphorylation | 0.76 |
| CTNNB1 | down-regulates activity | phosphorylation | 0.76 |
| CAV1 | down-regulates activity | phosphorylation | 0.76 |
| STAT5A | up-regulates | phosphorylation | 0.75 |
| PTPRA | up-regulates activity | phosphorylation | 0.74 |
| CDC42 | up-regulates | phosphorylation | 0.69 |
| ARRB1 | down-regulates | phosphorylation | 0.68 |
| CAV2 | down-regulates | phosphorylation | 0.68 |
| RAPGEF1 | up-regulates | phosphorylation | 0.67 |
| TIAM1 | up-regulates | phosphorylation | 0.66 |
| PTK2 | up-regulates | phosphorylation | 0.65 |
| EZR | up-regulates | phosphorylation | 0.65 |
| SH3GL1 | down-regulates | phosphorylation | 0.64 |
| PTK2B | up-regulates | phosphorylation | 0.62 |
| RAC1 | up-regulates | phosphorylation | 0.61 |
| HSP90AB1 | up-regulates | phosphorylation | 0.59 |
| GJA1 | down-regulates | phosphorylation | 0.59 |
| RRAS | down-regulates activity | phosphorylation | 0.58 |
| PDPK1 | up-regulates activity | phosphorylation | 0.58 |
| CDH5 | up-regulates | phosphorylation | 0.57 |
| SPRY2 | up-regulates | phosphorylation | 0.56 |
| ANXA2 | up-regulates | phosphorylation | 0.55 |
| DAG1 | down-regulates | phosphorylation | 0.55 |
| PTEN | down-regulates | phosphorylation | 0.54 |
| CBLC | up-regulates | phosphorylation | 0.54 |
| PRKCI | up-regulates | phosphorylation | 0.53 |
| PTPN6 | up-regulates | phosphorylation | 0.53 |
| FLT4 | up-regulates | phosphorylation | 0.51 |
| CDKN1B | down-regulates | phosphorylation | 0.50 |
| WWOX | up-regulates | phosphorylation | 0.48 |
| PLSCR1 | up-regulates activity | phosphorylation | 0.48 |
| MPZL1 | up-regulates | phosphorylation | 0.47 |
| DGKA | up-regulates | phosphorylation | 0.46 |
| CASP8 | down-regulates | phosphorylation | 0.45 |
| MMP14 | unknown | phosphorylation | 0.43 |
| TERT | down-regulates | phosphorylation | 0.42 |
| WASF1 | up-regulates | phosphorylation | 0.41 |
| NOXA1 | up-regulates | phosphorylation | 0.41 |
| PRKD1 | up-regulates | phosphorylation | 0.41 |
| ARHGDIA | down-regulates | phosphorylation | 0.40 |
| CDH2 | down-regulates | phosphorylation | 0.40 |
| LRP1 | up-regulates activity | phosphorylation | 0.39 |
| KIT | up-regulates activity | phosphorylation | 0.39 |
| DDR2 | up-regulates | phosphorylation | 0.38 |
| HCN4 | up-regulates | phosphorylation | 0.37 |
| IKBKB | up-regulates activity | phosphorylation | 0.36 |
| RPS6KA3 | up-regulates | phosphorylation | 0.35 |
| VAV3 | up-regulates | phosphorylation | 0.33 |
| FBXO5 | up-regulates | phosphorylation | 0.32 |
Section 10: Drug & Pharmacology Data
ChEMBL Target Information
| ChEMBL ID | Type | Description |
|---|
| CHEMBL267 | SINGLE PROTEIN | Proto-oncogene tyrosine-protein kinase Src |
| CHEMBL2363074 | PROTEIN FAMILY | SRC |
| CHEMBL2111336 | SELECTIVITY GROUP | VEGF-receptor 2 and tyrosine-protein kinase SRC |
| CHEMBL4523978 | SELECTIVITY GROUP | Src/Lck kinase |
| CHEMBL3885535 | PROTEIN-PROTEIN INTERACTION | Calmodulin/SRC |
| CHEMBL4523733 | PROTEIN-PROTEIN INTERACTION | VHL/SRC |
| CHEMBL4630728 | PROTEIN-PROTEIN INTERACTION | Cereblon/SRC |
FDA-Approved Drugs Targeting SRC (Phase 4)
| ChEMBL ID | Drug Name | Type | Phase |
|---|
| CHEMBL1421/CHEMBL5416410 | DASATINIB | Small molecule | 4 |
| CHEMBL288441 | BOSUTINIB | Small molecule | 4 |
| CHEMBL255863 | NILOTINIB | Small molecule | 4 |
| CHEMBL941 | IMATINIB | Small molecule | 4 |
| CHEMBL1336 | SORAFENIB | Small molecule | 4 |
| CHEMBL535 | SUNITINIB | Small molecule | 4 |
| CHEMBL477772 | PAZOPANIB | Small molecule | 4 |
| CHEMBL24828 | VANDETANIB | Small molecule | 4 |
| CHEMBL939 | GEFITINIB | Small molecule | 4 |
| CHEMBL553 | ERLOTINIB | Small molecule | 4 |
| CHEMBL554 | LAPATINIB | Small molecule | 4 |
| CHEMBL1173655 | AFATINIB | Small molecule | 4 |
| CHEMBL180022 | NERATINIB | Small molecule | 4 |
| CHEMBL2110732 | DACOMITINIB | Small molecule | 4 |
| CHEMBL1873475 | IBRUTINIB | Small molecule | 4 |
| CHEMBL2403108 | CERITINIB | Small molecule | 4 |
| CHEMBL3545311 | BRIGATINIB | Small molecule | 4 |
| CHEMBL1983268 | ENTRECTINIB | Small molecule | 4 |
| CHEMBL4298138 | REPOTRECTINIB | Small molecule | 4 |
| CHEMBL601719 | CRIZOTINIB | Small molecule | 4 |
| CHEMBL2105717 | CABOZANTINIB | Small molecule | 4 |
| CHEMBL1171837 | PONATINIB | Small molecule | 4 |
| CHEMBL608533 | MIDOSTAURIN | Small molecule | 4 |
| CHEMBL502835 | NINTEDANIB | Small molecule | 4 |
| CHEMBL1287853 | FEDRATINIB | Small molecule | 4 |
| CHEMBL1289494 | TIVOZANIB | Small molecule | 4 |
| CHEMBL1834657/1852688 | INFIGRATINIB | Small molecule | 4 |
| CHEMBL571546 | TIRBANIBULIN | Small molecule | 4 |
| CHEMBL1448 | NICLOSAMIDE | Small molecule | 4 |
Phase 3 Clinical Candidates
| ChEMBL ID | Drug Name | Type | Phase |
|---|
| CHEMBL217092 | SARACATINIB | Small molecule | 3 |
| CHEMBL1908391 | MASITINIB | Small molecule | 3 |
| CHEMBL223360 | LINIFANIB | Small molecule | 3 |
| CHEMBL31965 | CANERTINIB | Small molecule | 3 |
| CHEMBL3544983 | TESEVATINIB | Small molecule | 3 |
| CHEMBL377300 | BRIVANIB | Small molecule | 3 |
| CHEMBL428690 | ALVOCIDIB | Small molecule | 3 |
| CHEMBL483158 | ALISERTIB | Small molecule | 3 |
| CHEMBL491473 | CEDIRANIB | Small molecule | 3 |
| CHEMBL50 | QUERCETIN | Small molecule | 3 |
| CHEMBL522892 | DOVITINIB | Small molecule | 3 |
| CHEMBL276711 | SEMAXANIB | Small molecule | 3 |
| CHEMBL599552 | INDIGO | Small molecule | 3 |
| CHEMBL603469 | LESTAURTINIB | Small molecule | 3 |
| CHEMBL103667 | DORAMAPIMOD | Small molecule | 2 |
PharmGKB Pharmacogenomics Entry
| Attribute | Value |
|---|
| PharmGKB ID | PA36111 |
| Gene Symbol | SRC |
| VIP Gene | Yes |
| Has CPIC Guideline | No |
| Chromosome | chr20 |
BindingDB Compounds
Total Binding Compounds: 4,955+
Examples of high-affinity SRC inhibitors with IC50 data available.
Section 11: Expression Profiles
Bgee Gene Expression Summary
| Attribute | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 236 |
| Total Absent Calls | 50 |
| Total Conditions Tested | 286 |
| Max Expression Score | 95.98 |
| Average Expression Score | 81.10 |
| Gold Quality Annotations | 242 |
Top 30 Expressing Tissues
| Rank | Tissue | Score | Quality |
|---|
| 1 | Body of stomach | 95.98 | Gold |
| 2 | Gall bladder | 95.89 | Gold |
| 3 | Rectum | 95.58 | Gold |
| 4 | Body of pancreas | 95.45 | Gold |
| 5 | Lower esophagus mucosa | 95.36 | Gold |
| 6 | Transverse colon | 95.11 | Gold |
| 7 | Ganglionic eminence | 94.92 | Gold |
| 8 | Cortical plate | 94.65 | Gold |
| 9 | Stomach | 94.25 | Gold |
| 10 | Ectocervix | 94.18 | Gold |
| 11 | Small intestine Peyer's patch | 94.16 | Gold |
| 12 | Body of uterus | 93.98 | Gold |
| 13 | Muscle layer of sigmoid colon | 93.83 | Gold |
| 14 | Mucosa of transverse colon | 93.62 | Gold |
| 15 | Mucosa of stomach | 93.52 | Gold |
| 16 | Ascending aorta | 93.25 | Gold |
| 17 | Small intestine | 93.15 | Gold |
| 18 | Thoracic aorta | 93.12 | Gold |
| 19 | Right testis | 92.96 | Gold |
| 20 | Endocervix | 92.93 | Gold |
| 21 | Esophagus mucosa | 92.91 | Gold |
| 22 | Ventricular zone | 92.88 | Gold |
| 23 | Metanephros cortex | 92.86 | Gold |
| 24 | Left testis | 92.75 | Gold |
| 25 | Right adrenal gland cortex | 92.73 | Gold |
| 26 | Right adrenal gland | 92.60 | Gold |
| 27 | Right ovary | 92.56 | Gold |
| 28 | Left uterine tube | 92.48 | Gold |
| 29 | Left adrenal gland | 92.48 | Gold |
| 30 | Left adrenal gland cortex | 92.40 | Gold |
Single-Cell Expression Data
| Dataset ID | Description | Species | Cells |
|---|
| E-HCAD-29 | GM-CSF-producing T helper cells | Homo sapiens | 78,686 |
Section 12: Disease Associations
Mendelian Disease Links (GenCC)
| Disease | Classification | Inheritance | Source |
|---|
| Thrombocytopenia 6 (OMIM:616937) | Strong | Autosomal dominant | PanelApp Australia |
| Thrombocytopenia 6 (OMIM:616937) | Limited | Autosomal dominant | Labcorp Genetics |
| Thrombocytopenia 6 (Orphanet:480851) | Supportive | Autosomal dominant | Orphanet |
| Colorectal cancer (OMIM:114500) | No Known Disease Relationship | Unknown | Labcorp Genetics |
Orphanet Disease Entry
| Orphanet ID | Disease Name | Type | Gene Count |
|---|
| 480851 | Hereditary thrombocytopenia with early-onset myelofibrosis | Disease | 1 |
HPO Phenotype Associations
Total Associated Phenotypes: 17
| HPO ID | Phenotype |
|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0001442 | Typified by somatic mosaicism |
| HP:0001873 | Thrombocytopenia |
| HP:0001892 | Abnormal bleeding |
| HP:0004406 | Spontaneous, recurrent epistaxis |
| HP:0011974 | Myelofibrosis |
| HP:0031020 | Bone marrow hypercellularity |
| HP:0000939 | Osteoporosis |
| HP:0000490 | Deeply set eye |
| HP:0000601 | Hypotelorism |
| HP:0002003 | Large forehead |
| HP:0003003 | Colon cancer |
| HP:0005584 | Renal cell carcinoma |
| HP:0006716 | Hereditary nonpolyposis colorectal carcinoma |
| HP:0006740 | Transitional cell carcinoma of the bladder |
| HP:0006753 | Neoplasm of the stomach |
| HP:0002891 | Uterine leiomyosarcoma |
GWAS Associations
| Study ID | Trait/Disease | P-value | Mapped Genes |
|---|
| GCST007843 | Rheumatoid arthritis | 4.0e-13 | SRC - RPL7AP14 |
| GCST003422 | Squamous cell carcinoma | 1.0e-06 | SRC |
| GCST001854 | Retinopathy in non-diabetics | 4.0e-06 | SRC - RPL7AP14 |
| GCST012488 | L1-L4 bone mineral density x serum urate interaction | 3.0e-06 | SRC |
SUMMARY STATISTICS
| Category | Count |
|---|
| Gene Identifiers | 5 databases |
| Transcripts (Ensembl) | 29 |
| RefSeq mRNAs (Human) | 2 (reviewed) |
| CCDS IDs | 1 |
| Exons (canonical) | 14 |
| UniProt Accessions | 2 |
| Protein Domains (InterPro) | 11 |
| PDB Structures | 79 |
| Orthologs | 3 (key model organisms) |
| Paralogs | 32 |
| ClinVar Variants | 111+ |
| SpliceAI Predictions | 3,484 |
| AlphaMissense Predictions | 3,468 |
| Reactome Pathways | 69 |
| GO Annotations | 121 |
| STRING Interactions | 9,720+ |
| IntAct Interactions | 801+ |
| SIGNOR Signaling Entries | 560+ |
| Regulatory TFs | 32 |
| Approved Drugs (Phase 4) | 29 |
| Phase 3 Candidates | 15 |
| BindingDB Compounds | 4,955+ |
| Expression Tissues | 236 (ubiquitous) |
| HPO Phenotypes | 17 |
| GWAS Associations | 4 |
Reference compiled from BioBTree integrated biological databases. Data current as of database version.